Expression of enhancer of zeste homolog 2 (EZH2) in Invasive neuroendocrine carcinoma of the breast

被引：0
|
作者：
Gong, Y. [1 ]
Chen, J. [2 ]
Radvanyi, L. [2 ]
Rosen, D. G. [1 ]
Wu, Y. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Onocl, Houston, TX 77030 USA
来源：
HISTOPATHOLOGY | 2012年 / 61卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
58
引用
收藏
页码：20 / 20
页数：1
相关论文
共 50 条
  • [41] Overexpression of Enhancer of Zeste Homolog 2(EZH2) and Focal Adhesion Kinase (FAK) - In High Grade Endometrium Carcinoma
    Zhou, J.
    Bandyopadhyay, S.
    Chen, Z.
    Hussein, Y.
    Alosh, B.
    Jazaerly, T.
    Hayek, K.
    Ali-Fehmi, R.
    LABORATORY INVESTIGATION, 2012, 92 : 304A - 304A
  • [42] Enhancer Zeste Homolog 2 (EZH2) expression is associated with a shorter time to the first systemic therapy in follicular lymphoma
    Szumera-Cieckiewicz, A.
    Sokol, K.
    Rymkiewicz, G.
    Paszkiewicz-Kozik, E.
    Poleszczuk, J.
    Borysiuk, A.
    Kotarska, M.
    Walewski, J.
    Prochorec-Sobieszek, M.
    VIRCHOWS ARCHIV, 2019, 475 : S51 - S51
  • [43] Enhancer of zeste homolog 2 (EZH2) inhibition in metastatic melanoma promotes tumor regression in vivo
    Sengupta, Deepanwita
    Avaritt, Nathan
    Shalin, Sara C.
    Tackett, Alan J.
    CANCER RESEARCH, 2016, 76
  • [44] Enhancer of Zeste Homolog 2 (EZH2) in COVID-19-Positive Acute Myeloid Leukemia
    Hamed, Nahla
    Gallab, Omar
    Abdelhalim, Reham
    Rezk, Mohamed
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S289 - S290
  • [45] Overexpression of enhancer of zeste homolog 2 (EZH2), focal adhesion kinase (FAK), and pFAK in high grade endometrial carcinoma
    Semaan, A.
    Mert, I.
    Solomon, L.
    Morris, R.
    Munkarah, A.
    Sood, A.
    Ali-Fehmi, R.
    GYNECOLOGIC ONCOLOGY, 2012, 125 : S164 - S165
  • [46] Enhancer of Zeste Homologue 2 (EZH2) expression in malignant and benign hepatic tumors
    Dezso, K.
    Szabo, V.
    Bugyik, E.
    Schlachter, K.
    Paku, S.
    Schaff, Z.
    Nagy, P.
    VIRCHOWS ARCHIV, 2012, 461 : S209 - S209
  • [47] Analysis of the correlation between Zeste enhancer homolog 2 (EZH2) mRNA expression and the prognosis of mesothelioma patients and immune infiltration
    Kui Fan
    Chuan-long Zhang
    Bo-hui Zhang
    Meng-qi Gao
    Yun-chuan Sun
    Scientific Reports, 12
  • [48] Characterization of enhancer of zeste homolog 2 (EZH2) expression, activity, and association with the tumor immune microenvironment in olfactory neuroblastoma (ONB)
    Xue, Elisabetta
    Krause, Harris Benjamin
    Elliott, Andrew
    Mehra, Ranee
    Florou, Vaia
    Kim, Chul
    Soares, Heloisa P.
    Lou, Emil
    Vanderwalde, Ari M.
    Spetzler, David
    Bracken-Clarke, Dara Mark
    London, Nyall R., Jr.
    Gulley, James L.
    Floudas, Charalampos S.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [49] Enhancer of zeste-homolog 2 (EZH2) expression and clinical outcomes in metastatic castrate resistant prostate cancer (mCRPC).
    Giridhar, Karthik
    Costello, Brian Addis
    Sosa, Carlos
    Huang, Haojie
    Kohli, Manish
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [50] Enhancer of Zeste Homologue 2 (EZH2) Expression Is Associated with Cell Proliferation in Medulloblastoma
    Shi, M.
    Qiu, J.
    Smith, T. W.
    Kilpatrick, D. L.
    Wang, W.
    MODERN PATHOLOGY, 2013, 26 : 418A - 418A
12345